Sterling Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Sterling Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.2K	Sell	116 -5,740	-98%	-$196K	﹤0.01%	2707
2026 Q1	$194K	Sell	5,856 -3,267	-36%	-$138K	﹤0.01%	1189
2025 Q4	$422K	Buy	9,123 +135	+2%	+$5.65K	0.01%	1020
2025 Q3	$314K	Buy	8,988 +8,906	+10,861%	+$310K	﹤0.01%	1176
2025 Q2	$2.42K	Buy	82 +49	+148%	+$1.4K	﹤0.01%	2872
2025 Q1	$985	Hold	33	–	–	﹤0.01%	2823
2024 Q4	$945	Hold	33	–	–	﹤0.01%	2953
2024 Q3	$1.27K	Buy	+33	New	+$1.18K	﹤0.01%	2403
2017 Q2	–	Sell	-16,815	Closed	-$169K	–	944
2017 Q1	$169K	Sell	16,815 -537	-3%	-$7.98K	﹤0.01%	927
2016 Q4	$270K	Buy	17,352 +5,352	+45%	+$88.9K	﹤0.01%	858
2016 Q3	$231K	Buy	+12,000	New	+$143K	﹤0.01%	846

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Sterling Capital Management's COLL Position: Q2 2026 in Review

Sterling Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 98% in Q2 2026, selling an estimated $196K and leaving 116 shares worth $4.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

Sterling Capital Management first reported a position in COLL in Q3 2016 and has held it in 11 quarters since. The position peaked at $422K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Sterling Capital Management held 116 shares of Collegium Pharmaceutical worth $4.2K as of Q2 2026.
Sterling Capital Management sold 5,740 Collegium Pharmaceutical shares in Q2 2026, an estimated $196K.
Collegium Pharmaceutical made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2707 holding.
Sterling Capital Management first reported a position in Collegium Pharmaceutical in Q3 2016 and has held it in 11 quarters since.
Sterling Capital Management's Collegium Pharmaceutical position peaked at $422K in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.